The Journal of Pathology, ISSN 0022-3417, 08/2013, Volume 230, Issue 4, pp. 420 - 429
Sessile serrated adenomas/polyps (SSA/Ps) are precursors of colon cancer, particularly those that exhibit microsatellite instability. Distinguishing SSA/Ps...
sessile serrated polyp/adenoma | annexin A10 | hyperplastic polyp | colon cancer | HYPERPLASTIC POLYPS | EMERGING ROLES | sessile serrated polyp | MICROSATELLITE INSTABILITY | PREVALENCE | PATHOLOGY | TUMORIGENICITY | ISLAND METHYLATOR PHENOTYPE | adenoma | ONCOLOGY | BRAF MUTATION | PATHWAY | COLORECTAL-CANCER | CARCINOMA | Immunohistochemistry | Predictive Value of Tests | Colonic Neoplasms - genetics | Oligonucleotide Array Sequence Analysis | Adenoma - genetics | Colonic Polyps - pathology | Humans | Middle Aged | Case-Control Studies | Colonic Polyps - genetics | Colonic Neoplasms - chemistry | Trefoil Factor-2 | Real-Time Polymerase Chain Reaction | Diagnosis, Differential | Biomarkers, Tumor - analysis | Gene Expression Profiling - methods | Adenoma - chemistry | Colonic Polyps - chemistry | Annexins - genetics | Annexins - analysis | Biopsy | Colonic Neoplasms - pathology | Adenoma - pathology | Aged | Biomarkers, Tumor - genetics | Cluster Analysis | Polyps (Pathology) | Colon cancer | DNA microarrays | Analysis | Genes | Genetic research | Gene expression | Medical research | Colon | Colorectal cancer | Adenoma
sessile serrated polyp/adenoma | annexin A10 | hyperplastic polyp | colon cancer | HYPERPLASTIC POLYPS | EMERGING ROLES | sessile serrated polyp | MICROSATELLITE INSTABILITY | PREVALENCE | PATHOLOGY | TUMORIGENICITY | ISLAND METHYLATOR PHENOTYPE | adenoma | ONCOLOGY | BRAF MUTATION | PATHWAY | COLORECTAL-CANCER | CARCINOMA | Immunohistochemistry | Predictive Value of Tests | Colonic Neoplasms - genetics | Oligonucleotide Array Sequence Analysis | Adenoma - genetics | Colonic Polyps - pathology | Humans | Middle Aged | Case-Control Studies | Colonic Polyps - genetics | Colonic Neoplasms - chemistry | Trefoil Factor-2 | Real-Time Polymerase Chain Reaction | Diagnosis, Differential | Biomarkers, Tumor - analysis | Gene Expression Profiling - methods | Adenoma - chemistry | Colonic Polyps - chemistry | Annexins - genetics | Annexins - analysis | Biopsy | Colonic Neoplasms - pathology | Adenoma - pathology | Aged | Biomarkers, Tumor - genetics | Cluster Analysis | Polyps (Pathology) | Colon cancer | DNA microarrays | Analysis | Genes | Genetic research | Gene expression | Medical research | Colon | Colorectal cancer | Adenoma
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2014, Volume 38, Issue 11, pp. 1577 - 1579
Journal Article
The Prostate, ISSN 0270-4137, 03/2017, Volume 77, Issue 4, pp. 337 - 349
BACKGROUND Statins have recently been studied for their proapoptotic and antimetastatic effects. However, the exact mechanisms of their anticancer actions...
S100 calcium binding protein A4 | prostate cancer | annexin A10 | statin | CONTROLLED-TRIAL | DIFFERENTIAL EXPRESSION | PLUS PREDNISONE | DOWN-REGULATION | CASTRATION | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | S100A4 | RECURRENCE | CARCINOMA | PROGRESSION | ENZALUTAMIDE | Simvastatin - therapeutic use | Humans | Cell Proliferation - physiology | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Simvastatin - pharmacology | Prostatic Neoplasms, Castration-Resistant - metabolism | Cell Movement - physiology | Prostatic Neoplasms, Castration-Resistant - pathology | Up-Regulation - drug effects | Cell Movement - drug effects | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Mice, Nude | Neoplasm Invasiveness - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Up-Regulation - physiology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Annexins - biosynthesis
S100 calcium binding protein A4 | prostate cancer | annexin A10 | statin | CONTROLLED-TRIAL | DIFFERENTIAL EXPRESSION | PLUS PREDNISONE | DOWN-REGULATION | CASTRATION | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | S100A4 | RECURRENCE | CARCINOMA | PROGRESSION | ENZALUTAMIDE | Simvastatin - therapeutic use | Humans | Cell Proliferation - physiology | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Simvastatin - pharmacology | Prostatic Neoplasms, Castration-Resistant - metabolism | Cell Movement - physiology | Prostatic Neoplasms, Castration-Resistant - pathology | Up-Regulation - drug effects | Cell Movement - drug effects | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Mice, Nude | Neoplasm Invasiveness - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Up-Regulation - physiology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Annexins - biosynthesis
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 04/2014, Volume 38, Issue 4, pp. 518 - 525
Differentiating sporadic microsatellite-unstable colorectal carcinoma due to MLH1 promoter hypermethylation from Lynch syndrome (LS)-associated tumors due to...
BRAF | MLH1 | Annexin A10 | Sessile serrated polyp | Lynch syndrome | SURGERY | PROMOTER HYPERMETHYLATION | INSTABILITY | DNA METHYLATION | sessile serrated polyp | PATHOLOGY | POLYPS | ISLAND METHYLATOR PHENOTYPE | REAL-TIME PCR | COLON-CANCER | annexin A10 | BRAF MUTATION | SESSILE SERRATED ADENOMAS | MLH1 METHYLATION | Immunohistochemistry | MutL Protein Homolog 1 | Diagnosis, Differential | Microsatellite Instability | Biomarkers, Tumor - analysis | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Humans | Male | Reverse Transcriptase Polymerase Chain Reaction | Colorectal Neoplasms - diagnosis | Annexins - analysis | Colorectal Neoplasms, Hereditary Nonpolyposis - metabolism | Colorectal Neoplasms, Hereditary Nonpolyposis - diagnosis | Adaptor Proteins, Signal Transducing - genetics | Female | Aged | Annexins - biosynthesis | Nuclear Proteins - genetics | Colorectal Neoplasms - metabolism
BRAF | MLH1 | Annexin A10 | Sessile serrated polyp | Lynch syndrome | SURGERY | PROMOTER HYPERMETHYLATION | INSTABILITY | DNA METHYLATION | sessile serrated polyp | PATHOLOGY | POLYPS | ISLAND METHYLATOR PHENOTYPE | REAL-TIME PCR | COLON-CANCER | annexin A10 | BRAF MUTATION | SESSILE SERRATED ADENOMAS | MLH1 METHYLATION | Immunohistochemistry | MutL Protein Homolog 1 | Diagnosis, Differential | Microsatellite Instability | Biomarkers, Tumor - analysis | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Humans | Male | Reverse Transcriptase Polymerase Chain Reaction | Colorectal Neoplasms - diagnosis | Annexins - analysis | Colorectal Neoplasms, Hereditary Nonpolyposis - metabolism | Colorectal Neoplasms, Hereditary Nonpolyposis - diagnosis | Adaptor Proteins, Signal Transducing - genetics | Female | Aged | Annexins - biosynthesis | Nuclear Proteins - genetics | Colorectal Neoplasms - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 4, pp. e0175039 - e0175039
Annexins are a multigene family of calcium and phospholipid-binding proteins that play important roles in calcium signaling, cell motility, differentiation and...
GENETICS | NEOPLASIA | MULTIDISCIPLINARY SCIENCES | MEMBRANE-BINDING PROTEINS | BIOLOGY | CONSENSUS | CLASSIFICATION | SERRATED PATHWAY | COLORECTAL-CARCINOMA | EXPRESSION | CANCER | Multigene Family - genetics | Pancreatic Neoplasms - blood | Adenocarcinoma - pathology | Annexins - metabolism | Adenocarcinoma - blood | CD24 Antigen - metabolism | Humans | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Pancreas - metabolism | Pancreatitis, Chronic - genetics | Carcinoma, Pancreatic Ductal - pathology | Annexins - genetics | Disease Progression | Pancreatic Ducts - metabolism | Biomarkers, Tumor - blood | Carcinoma, Pancreatic Ductal - blood | Pancreatitis, Chronic - pathology | Pancreatitis, Chronic - blood | CD24 Antigen - blood | Biomarkers, Tumor - metabolism | Adenocarcinoma - genetics | Annexins - blood | Adenocarcinoma | Development and progression | Annexins | Health aspects | Risk factors | Index Medicus | Calcium | Epithelial cells | Differentiation (biology) | Phospholipids | Tissue analysis | Tissues | Calcium signalling | Proteins | Precursors | Quality | Rodents | Surgery | Classification | Lesions | Pancreas | Statistical analysis | Tumor cells | Ducts | Pancreatitis | Mass spectroscopy | Statistics | Pathology | Pancreatic cancer | Proteomics | Mass spectrometry | Binding sites | Cancer | Tumors
GENETICS | NEOPLASIA | MULTIDISCIPLINARY SCIENCES | MEMBRANE-BINDING PROTEINS | BIOLOGY | CONSENSUS | CLASSIFICATION | SERRATED PATHWAY | COLORECTAL-CARCINOMA | EXPRESSION | CANCER | Multigene Family - genetics | Pancreatic Neoplasms - blood | Adenocarcinoma - pathology | Annexins - metabolism | Adenocarcinoma - blood | CD24 Antigen - metabolism | Humans | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Pancreas - metabolism | Pancreatitis, Chronic - genetics | Carcinoma, Pancreatic Ductal - pathology | Annexins - genetics | Disease Progression | Pancreatic Ducts - metabolism | Biomarkers, Tumor - blood | Carcinoma, Pancreatic Ductal - blood | Pancreatitis, Chronic - pathology | Pancreatitis, Chronic - blood | CD24 Antigen - blood | Biomarkers, Tumor - metabolism | Adenocarcinoma - genetics | Annexins - blood | Adenocarcinoma | Development and progression | Annexins | Health aspects | Risk factors | Index Medicus | Calcium | Epithelial cells | Differentiation (biology) | Phospholipids | Tissue analysis | Tissues | Calcium signalling | Proteins | Precursors | Quality | Rodents | Surgery | Classification | Lesions | Pancreas | Statistical analysis | Tumor cells | Ducts | Pancreatitis | Mass spectroscopy | Statistics | Pathology | Pancreatic cancer | Proteomics | Mass spectrometry | Binding sites | Cancer | Tumors
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2015, Volume 21, Issue 33, pp. 9749 - 9757
AIM: To validate the utility of Annexin A10 as a surrogate marker of the serrated neoplasia pathway in invasive colorectal cancers(CRCs).METHODS: A total of...
A10;Serrated | pathway;CpG | island | Annexin | neoplasia | CpG island methylator phenotype | Serrated neoplasia pathway | Annexin A10 | Colorectal cancer | BRAF mutation | MARKER | MICROSATELLITE INSTABILITY | ADENOCARCINOMA | ANTIBODY | COLON | LYNCH SYNDROME | ISLAND METHYLATOR PHENOTYPE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Predictive Value of Tests | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) - genetics | Tissue Array Analysis | Colorectal Neoplasms - genetics | Humans | Middle Aged | Colorectal Neoplasms - chemistry | Male | Colorectal Neoplasms - therapy | DNA Methylation | DNA Mutational Analysis | Female | Retrospective Studies | Republic of Korea | Colorectal Neoplasms - mortality | Reproducibility of Results | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Risk Factors | Hospitals, University | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Annexins - analysis | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | CpG Islands | Aged | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Retrospective Study
A10;Serrated | pathway;CpG | island | Annexin | neoplasia | CpG island methylator phenotype | Serrated neoplasia pathway | Annexin A10 | Colorectal cancer | BRAF mutation | MARKER | MICROSATELLITE INSTABILITY | ADENOCARCINOMA | ANTIBODY | COLON | LYNCH SYNDROME | ISLAND METHYLATOR PHENOTYPE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Predictive Value of Tests | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) - genetics | Tissue Array Analysis | Colorectal Neoplasms - genetics | Humans | Middle Aged | Colorectal Neoplasms - chemistry | Male | Colorectal Neoplasms - therapy | DNA Methylation | DNA Mutational Analysis | Female | Retrospective Studies | Republic of Korea | Colorectal Neoplasms - mortality | Reproducibility of Results | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Risk Factors | Hospitals, University | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Annexins - analysis | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | CpG Islands | Aged | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Retrospective Study
Journal Article
MEDICAL SCIENCE MONITOR, ISSN 1643-3750, 07/2019, Volume 25, pp. 5666 - 5673
Background: Epithelial ovarian cancer (EOC) is a gynecological malignancy that is associated with high mortality. Annexin A10 (ANXA10) is variably expressed in...
MEDICINE, RESEARCH & EXPERIMENTAL | Prognosis | Neoplasm Invasiveness | STATISTICS | DYSREGULATION | Chemotherapy, Adjuvant | Ovarian Neoplasms | Annexins
MEDICINE, RESEARCH & EXPERIMENTAL | Prognosis | Neoplasm Invasiveness | STATISTICS | DYSREGULATION | Chemotherapy, Adjuvant | Ovarian Neoplasms | Annexins
Journal Article
Virchows Archiv, ISSN 0945-6317, 1/2015, Volume 466, Issue 1, pp. 5 - 12
Serrated adenocarcinoma (SAC), representing at least 10 % of colorectal carcinomas (CRC), differs from conventional carcinomas not only by its histology, but...
Immunohistochemistry | Pathology | Medicine & Public Health | Colorectal cancer | Serrated adenocarcinoma | BRAF | Annexin A10 | METHYLATION | MICROSATELLITE INSTABILITY | PREVALENCE | PATHOLOGY | CANCER | POLYPS | MUTATIONS | EXPRESSION | PROGRESSION | ras Proteins - genetics | Adenoma - diagnosis | Diagnosis, Differential | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Annexins - metabolism | Humans | Middle Aged | Male | Proto-Oncogene Proteins - genetics | Mutation - genetics | Case-Control Studies | Colorectal Neoplasms - diagnosis | Adenoma - metabolism | Adenocarcinoma - diagnosis | Adenocarcinoma - metabolism | Proto-Oncogene Proteins B-raf - genetics | Sensitivity and Specificity | Adenoma - pathology | Biomarkers, Tumor - metabolism | Female | Aged | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Gene mutations
Immunohistochemistry | Pathology | Medicine & Public Health | Colorectal cancer | Serrated adenocarcinoma | BRAF | Annexin A10 | METHYLATION | MICROSATELLITE INSTABILITY | PREVALENCE | PATHOLOGY | CANCER | POLYPS | MUTATIONS | EXPRESSION | PROGRESSION | ras Proteins - genetics | Adenoma - diagnosis | Diagnosis, Differential | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Annexins - metabolism | Humans | Middle Aged | Male | Proto-Oncogene Proteins - genetics | Mutation - genetics | Case-Control Studies | Colorectal Neoplasms - diagnosis | Adenoma - metabolism | Adenocarcinoma - diagnosis | Adenocarcinoma - metabolism | Proto-Oncogene Proteins B-raf - genetics | Sensitivity and Specificity | Adenoma - pathology | Biomarkers, Tumor - metabolism | Female | Aged | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Gene mutations
Journal Article
Neuroscience Letters, ISSN 0304-3940, 09/2016, Volume 631, pp. 1 - 6
ANXA10 (annexin A10) is a member of the annexin family, and its biological effects are mediated primarily through the calcium-dependent phospholipid-binding...
Spinal nerve ligation | Spinal cord | Mice | Anxa10 | Neuropathic pain | TARGET | CENTRAL SENSITIZATION | SPINAL-CORD | CANCER | NEUROSCIENCES | MEMBRANE DYNAMICS | EXPRESSION | NOCICEPTION | Up-Regulation | Neuralgia - genetics | Spinal Cord - metabolism | Annexins - metabolism | Hyperalgesia - metabolism | Humans | Neuralgia - metabolism | Male | RNA, Messenger - metabolism | Annexins - genetics | Mice, Inbred ICR | Animals | Ligation | Hyperalgesia - genetics | HEK293 Cells | Neurons - metabolism | Neuralgia - physiopathology | Annexins - physiology | Spinal Nerves - injuries | Astrocytes - metabolism | Gene expression | Safety and security measures | Food | Phosphates | Care and treatment | Pain | DNA microarrays | RNA | Genes | Annexins
Spinal nerve ligation | Spinal cord | Mice | Anxa10 | Neuropathic pain | TARGET | CENTRAL SENSITIZATION | SPINAL-CORD | CANCER | NEUROSCIENCES | MEMBRANE DYNAMICS | EXPRESSION | NOCICEPTION | Up-Regulation | Neuralgia - genetics | Spinal Cord - metabolism | Annexins - metabolism | Hyperalgesia - metabolism | Humans | Neuralgia - metabolism | Male | RNA, Messenger - metabolism | Annexins - genetics | Mice, Inbred ICR | Animals | Ligation | Hyperalgesia - genetics | HEK293 Cells | Neurons - metabolism | Neuralgia - physiopathology | Annexins - physiology | Spinal Nerves - injuries | Astrocytes - metabolism | Gene expression | Safety and security measures | Food | Phosphates | Care and treatment | Pain | DNA microarrays | RNA | Genes | Annexins
Journal Article
Cellular and Molecular Life Sciences, ISSN 1420-682X, 1/2014, Volume 71, Issue 2, pp. 311 - 329
Annexin A10 is the latest identified member of the annexin family of Ca2+- and phospholipid-binding proteins. In previous studies, downregulation of annexin...
Life Sciences | Biochemistry, general | Nucleolar caps | Life Sciences, general | Paraspeckles | Annexin A10 | Biomedicine general | Cell Biology | Apoptosis | F-ACTIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACUTE MYELOID-LEUKEMIA | I-HETEROTETRAMER | CELL BIOLOGY | MYC MESSENGER-RNA | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | CA2+-BINDING SITES | INVERTED REPEATS | BINDING PROTEINS | Antibiotics, Antineoplastic - toxicity | RNA Polymerase II - antagonists & inhibitors | Annexins - metabolism | Apoptosis - drug effects | Calcium - metabolism | Humans | Nuclear Proteins - metabolism | RNA Polymerase II - metabolism | Cell Nucleus - ultrastructure | RNA, Messenger - metabolism | Annexins - genetics | Doxorubicin - toxicity | PTB-Associated Splicing Factor | Annexins - analysis | Animals | Cell Nucleus - metabolism | Protein Isoforms - metabolism | Dogs | Madin Darby Canine Kidney Cells | HeLa Cells | RNA-Binding Proteins - metabolism | Development and progression | Genetic transcription | RNA | Binding proteins | Tumors | Protein binding | Proteins | Signal transduction | Biochemistry | Gene expression
Life Sciences | Biochemistry, general | Nucleolar caps | Life Sciences, general | Paraspeckles | Annexin A10 | Biomedicine general | Cell Biology | Apoptosis | F-ACTIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACUTE MYELOID-LEUKEMIA | I-HETEROTETRAMER | CELL BIOLOGY | MYC MESSENGER-RNA | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | CA2+-BINDING SITES | INVERTED REPEATS | BINDING PROTEINS | Antibiotics, Antineoplastic - toxicity | RNA Polymerase II - antagonists & inhibitors | Annexins - metabolism | Apoptosis - drug effects | Calcium - metabolism | Humans | Nuclear Proteins - metabolism | RNA Polymerase II - metabolism | Cell Nucleus - ultrastructure | RNA, Messenger - metabolism | Annexins - genetics | Doxorubicin - toxicity | PTB-Associated Splicing Factor | Annexins - analysis | Animals | Cell Nucleus - metabolism | Protein Isoforms - metabolism | Dogs | Madin Darby Canine Kidney Cells | HeLa Cells | RNA-Binding Proteins - metabolism | Development and progression | Genetic transcription | RNA | Binding proteins | Tumors | Protein binding | Proteins | Signal transduction | Biochemistry | Gene expression
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e45510
Background: Annexins are calcium and phospholipid binding proteins that form an evolutionary conserved multigene family. Considerable evidence indicates that...
HEPATOCELLULAR-CARCINOMA | PROTEIN | CYCLIN D1 EXPRESSION | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | SQUAMOUS-CELL CARCINOMA | DOWN-REGULATION | PROLIFERATION | KINASE ACTIVATION | ACUTE PROMYELOCYTIC LEUKEMIA | Cell Cycle - genetics | Annexins - metabolism | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Mouth Neoplasms - metabolism | Annexins - genetics | Gene Knockdown Techniques | MAP Kinase Signaling System | RNA Interference | Aged, 80 and over | Cell Line, Tumor | Mouth Neoplasms - pathology | Female | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Mouth Neoplasms - genetics | Physiological aspects | Development and progression | Genetic aspects | Research | Annexins | Mouth cancer | Mitogen-activated protein kinases | Cell proliferation | Immunohistochemistry | RNA-directed DNA polymerase | Calcium | Oral cancer | Immunoblotting | Phospholipids | Kinases | Inactivation | Carcinogenesis | Small intestine | Maxillofacial surgery | Proteins | Cyclin-dependent kinase | Carcinogens | Evolutionary conservation | Rodents | Surgery | Bioindicators | Cyclin-dependent kinase inhibitors | G1 phase | Squamous cell carcinoma | Deactivation | Cloning | Cyclin-dependent kinases | Extracellular signal-regulated kinase | MAP kinase | Oral squamous cell carcinoma | Dentistry | Gene expression | Polymerase chain reaction | Medicine | Signaling | Biomarkers | Protein expression | Molecular biology
HEPATOCELLULAR-CARCINOMA | PROTEIN | CYCLIN D1 EXPRESSION | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | SQUAMOUS-CELL CARCINOMA | DOWN-REGULATION | PROLIFERATION | KINASE ACTIVATION | ACUTE PROMYELOCYTIC LEUKEMIA | Cell Cycle - genetics | Annexins - metabolism | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Mouth Neoplasms - metabolism | Annexins - genetics | Gene Knockdown Techniques | MAP Kinase Signaling System | RNA Interference | Aged, 80 and over | Cell Line, Tumor | Mouth Neoplasms - pathology | Female | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Mouth Neoplasms - genetics | Physiological aspects | Development and progression | Genetic aspects | Research | Annexins | Mouth cancer | Mitogen-activated protein kinases | Cell proliferation | Immunohistochemistry | RNA-directed DNA polymerase | Calcium | Oral cancer | Immunoblotting | Phospholipids | Kinases | Inactivation | Carcinogenesis | Small intestine | Maxillofacial surgery | Proteins | Cyclin-dependent kinase | Carcinogens | Evolutionary conservation | Rodents | Surgery | Bioindicators | Cyclin-dependent kinase inhibitors | G1 phase | Squamous cell carcinoma | Deactivation | Cloning | Cyclin-dependent kinases | Extracellular signal-regulated kinase | MAP kinase | Oral squamous cell carcinoma | Dentistry | Gene expression | Polymerase chain reaction | Medicine | Signaling | Biomarkers | Protein expression | Molecular biology
Journal Article
International Journal of Neuroscience, ISSN 0020-7454, 02/2018, Volume 128, Issue 2, pp. 125 - 132
Purpose: The current study aims at investigating the downstream targets of spinal Annexin A10 in modulating neuropathic pain. Materials and methods: Paw...
ERK1/2 | pain | TNF-α | IL-1β | Annexin A10 | TNF-alpha | RECEPTOR | IL-1 beta | NEUROSCIENCES | NEUROPATHIC PAIN | MAINTENANCE | INHIBITION | PATHWAY | MICE | HYPERALGESIA | NOCICEPTION | Peripheral Nerve Injuries - complications | Physical Stimulation | Tumor Necrosis Factor-alpha - metabolism | MAP Kinase Signaling System - physiology | Phosphorylation | Spinal Cord - metabolism | Annexins - metabolism | Hyperalgesia - metabolism | Neuralgia - metabolism | Rats | Male | Rats, Sprague-Dawley | Annexins - genetics | Gene Knockdown Techniques | Animals | Interleukin-1beta - metabolism | Peripheral Nerve Injuries - metabolism | Neuralgia - etiology | Hyperalgesia - etiology | RNA, Small Interfering | Disease Models, Animal
ERK1/2 | pain | TNF-α | IL-1β | Annexin A10 | TNF-alpha | RECEPTOR | IL-1 beta | NEUROSCIENCES | NEUROPATHIC PAIN | MAINTENANCE | INHIBITION | PATHWAY | MICE | HYPERALGESIA | NOCICEPTION | Peripheral Nerve Injuries - complications | Physical Stimulation | Tumor Necrosis Factor-alpha - metabolism | MAP Kinase Signaling System - physiology | Phosphorylation | Spinal Cord - metabolism | Annexins - metabolism | Hyperalgesia - metabolism | Neuralgia - metabolism | Rats | Male | Rats, Sprague-Dawley | Annexins - genetics | Gene Knockdown Techniques | Animals | Interleukin-1beta - metabolism | Peripheral Nerve Injuries - metabolism | Neuralgia - etiology | Hyperalgesia - etiology | RNA, Small Interfering | Disease Models, Animal
Journal Article
Histopathology, ISSN 0309-0167, 11/2013, Volume 63, Issue 5, pp. 640 - 648
Aims Annexin A10 (ANXA10) is a calcium‐ and phospholipid‐binding protein expressed normally in the gastric mucosa. In this study, we evaluated the potential...
cancer of an unknown primary site | annexin A10 | immunohistochemistry | Immunohistochemistry | Annexin A10 | Cancer of an unknown primary site | PATHOLOGY | UNKNOWN PRIMARY | CANCER | TUMORS | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | POOR-PROGNOSIS | EXPRESSION | PROGRESSION | Diagnosis, Differential | Pancreatic Neoplasms - metabolism | Stomach Neoplasms - diagnosis | Annexins - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Stomach Neoplasms - metabolism | Stomach - metabolism | Gastric Mucosa - metabolism | Biliary Tract Neoplasms - diagnosis | Adenocarcinoma - diagnosis | Adenocarcinoma - metabolism | Biliary Tract Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Adenocarcinoma | Liver cancer | Gastrointestinal system | Protein binding | Mucous membrane
cancer of an unknown primary site | annexin A10 | immunohistochemistry | Immunohistochemistry | Annexin A10 | Cancer of an unknown primary site | PATHOLOGY | UNKNOWN PRIMARY | CANCER | TUMORS | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | GASTRIC-CARCINOMA | POOR-PROGNOSIS | EXPRESSION | PROGRESSION | Diagnosis, Differential | Pancreatic Neoplasms - metabolism | Stomach Neoplasms - diagnosis | Annexins - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Stomach Neoplasms - metabolism | Stomach - metabolism | Gastric Mucosa - metabolism | Biliary Tract Neoplasms - diagnosis | Adenocarcinoma - diagnosis | Adenocarcinoma - metabolism | Biliary Tract Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Adenocarcinoma | Liver cancer | Gastrointestinal system | Protein binding | Mucous membrane
Journal Article
Modern Pathology, ISSN 0893-3952, 02/2015, Volume 28, Issue 2, pp. 268 - 278
Annexin A10 (ANXA10) is a member of the ANX family that is normally expressed in gastric mucosa. ANXA10 was recently observed to be upregulated in sessile...
ISLAND METHYLATOR PHENOTYPE | MOLECULAR-FEATURES | DNA METHYLATION | BRAF MUTATION | MARKER | DIETARY FIBER | ADENOMA | PATHOLOGY | CANCER | MUC6 | POLYPS | Immunohistochemistry | Microsatellite Instability | Adenocarcinoma - pathology | Biomarkers, Tumor - analysis | Colorectal Neoplasms - genetics | Humans | Precancerous Conditions - metabolism | Stomach - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Cell Transformation, Neoplastic - metabolism | Precancerous Conditions - genetics | DNA Methylation | Phenotype | Adenocarcinoma - metabolism | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | CpG Islands | Precancerous Conditions - pathology | Adenocarcinoma - genetics | Annexins - biosynthesis | Cell Transformation, Neoplastic - pathology | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism
ISLAND METHYLATOR PHENOTYPE | MOLECULAR-FEATURES | DNA METHYLATION | BRAF MUTATION | MARKER | DIETARY FIBER | ADENOMA | PATHOLOGY | CANCER | MUC6 | POLYPS | Immunohistochemistry | Microsatellite Instability | Adenocarcinoma - pathology | Biomarkers, Tumor - analysis | Colorectal Neoplasms - genetics | Humans | Precancerous Conditions - metabolism | Stomach - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Cell Transformation, Neoplastic - metabolism | Precancerous Conditions - genetics | DNA Methylation | Phenotype | Adenocarcinoma - metabolism | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | CpG Islands | Precancerous Conditions - pathology | Adenocarcinoma - genetics | Annexins - biosynthesis | Cell Transformation, Neoplastic - pathology | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism
Journal Article
APMIS, ISSN 0903-4641, 12/2014, Volume 122, Issue 12, pp. 1187 - 1195
Annexin A10 (ANXA10) has recently been identified as a marker of sessile serrated adenomas/polyps of the colorectum. Although the serrated neoplasia pathway is...
microsatellite instability | colorectal cancer | Annexin A10 | serrated pathway | Serrated pathway | Microsatellite instability | Colorectal cancer | MOLECULAR-FEATURES | HYPERPLASTIC POLYPS | ADENOCARCINOMA | MICROBIOLOGY | COLON | IMMUNOLOGY | PATHOLOGY | CANCER | ISLAND METHYLATOR PHENOTYPE | BRAF MUTATION | GASTRIC-CARCINOMA | KRAS | ADENOMAS | Immunohistochemistry | MutL Protein Homolog 1 | ras Proteins - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | ras Proteins - metabolism | Male | DNA Methylation | DNA Mismatch Repair | Biomarkers, Tumor - metabolism | Female | Nuclear Proteins - genetics | Microsatellite Repeats | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins - metabolism | Promoter Regions, Genetic | Annexins - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Annexins - genetics | Proto-Oncogene Proteins B-raf - genetics | Adaptor Proteins, Signal Transducing - genetics | CpG Islands - genetics | Biomarkers, Tumor - genetics | Mutation | Adaptor Proteins, Signal Transducing - metabolism | Genetic aspects | Methylation | Analysis | Cancer
microsatellite instability | colorectal cancer | Annexin A10 | serrated pathway | Serrated pathway | Microsatellite instability | Colorectal cancer | MOLECULAR-FEATURES | HYPERPLASTIC POLYPS | ADENOCARCINOMA | MICROBIOLOGY | COLON | IMMUNOLOGY | PATHOLOGY | CANCER | ISLAND METHYLATOR PHENOTYPE | BRAF MUTATION | GASTRIC-CARCINOMA | KRAS | ADENOMAS | Immunohistochemistry | MutL Protein Homolog 1 | ras Proteins - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | ras Proteins - metabolism | Male | DNA Methylation | DNA Mismatch Repair | Biomarkers, Tumor - metabolism | Female | Nuclear Proteins - genetics | Microsatellite Repeats | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins - metabolism | Promoter Regions, Genetic | Annexins - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Annexins - genetics | Proto-Oncogene Proteins B-raf - genetics | Adaptor Proteins, Signal Transducing - genetics | CpG Islands - genetics | Biomarkers, Tumor - genetics | Mutation | Adaptor Proteins, Signal Transducing - metabolism | Genetic aspects | Methylation | Analysis | Cancer
Journal Article